Betavariant recombinant booster vaccine elicits broad crossreactive neutralization of SARSCoV2 including Omicron variants

Simple item page
dc.article.end-page10en
dc.article.start-page1en
dc.citation.doi10.1016/J.HELIYON.2024.E27033en
dc.contributor.authorDelphine Planasen
dc.contributor.authorLin Pengen
dc.contributor.authorLingyi Zhengen
dc.contributor.authorFlorence Guivel-Benhassineen
dc.contributor.authorJinal Bhimanen
dc.contributor.authorPenelope Mooreen
dc.contributor.authorE et alen
dc.date.accessioned2024-09-16T10:05:44Z
dc.date.available2024-09-16T10:05:44Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn2405-8440en
dc.identifier.urihttps://hdl.handle.net/10539/40799
dc.journal.titleBetavariant recombinant booster vaccine elicits broad crossreactive neutralization of SARSCoV2 including Omicron variantsen
dc.journal.volume10en
dc.titleBetavariant recombinant booster vaccine elicits broad crossreactive neutralization of SARSCoV2 including Omicron variantsen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
2.14 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download
Collections
Academic Wits Research Outputs (All submissions)